{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-071923","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2025-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.760817+00:00","generated_at":"2026-05-23T22:17:57.682975+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Globus Medical completes acquisition of Nevro Corp. for $5.85/share cash","bullets":["Completed acquisition of Nevro on April 3, 2025; each Nevro share received $5.85 in cash.","Nevro stock options and RSUs canceled; RSUs converted to cash equal to Merger Consideration.","Acquisition expands Globus's addressable market opportunity to $2 billion in neuromodulation.","Nevro common stock ceased trading on NYSE as of April 3, 2025.","Globus plans to discuss merger benefits during Q1 2025 earnings call in May."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-071923","json":"https://secwatch.observer/filing/0001193125-25-071923.json","markdown":"https://secwatch.observer/filing/0001193125-25-071923.md","text":"https://secwatch.observer/filing/0001193125-25-071923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/0001193125-25-071923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525071923/d931031d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T22:17:57.682975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}